Exponent Inc (EXPO)
Official siteINDUSTRIALS • ENGINEERING & CONSTRUCTION • NASDAQ
Market Cap: $4.15B
Last updated: Nov 17, 2026 at 11:06 AM ET
Exponent Inc (EXPO) Stock Forecast
Analysts expect Exponent (EXPO) to earn $2.57 per share in the fiscal year ending Dec 31, 2026, on revenue of $613.75M. Of 4 analysts, 3 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 3 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 75% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 25.0% |
| Buy | 2 | 50.0% |
| Hold | 1 | 25.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 4
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 13.6% and revenue estimates rise 9.0%.
- Fiscal year ending Dec 31, 2026
- $2.57
- EPS consensus, revenue $613.75M
- Fiscal year ending Dec 31, 2027
- $2.92
- EPS consensus, revenue $668.69M
- Next report
- Feb 3, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $2.57 | $2.36 to $2.77 | 4 | $613.75M | $593.18M to $672.51M | 4 |
| Dec 31, 2027 | $2.92 | $2.62 to $3.32 | 4 | $668.69M | $642.42M to $743.84M | 4 |
Quarterly Estimates
The EPS consensus rises from $0.54 for the quarter ending Dec 31, 2026 to $0.86 for the quarter ending Mar 31, 2027.
EPS range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.54 | $0.51 to $0.57 | 6 | $148.33M | $136.22M to $169.05M | 6 |
| Mar 31, 2027 | $0.86 | $0.86 to $0.86 | 1 | N/A | N/A | 0 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 7 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 3 | 0 |
| Fiscal year ending Dec 31, 2027 | 3 | 0 |
| Quarter ending Mar 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 2.4% from $2.51.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $2.57 | $2.41 | $2.41 | $2.51 | $2.51 | +2.2% |
| Fiscal year ending Dec 31, 2027 | $2.92 | $2.72 | $2.72 | $2.84 | $2.84 | +2.8% |
| Quarter ending Mar 31, 2027 | $0.86 | $0.66 | $0.66 | $0.63 | $0.63 | +36.5% |
Frequently Asked Questions About EXPO
What is the EXPO stock forecast?
Consensus analyst estimates put Exponent's EPS at $2.57 for the fiscal year ending Dec 31, 2026, on revenue of $613.75M. The consensus rating from 4 analysts is Buy.
How do analysts rate EXPO stock?
Of 4 analysts covering Exponent, 1 rates it Strong Buy, 2 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from EXPO next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $2.57, with estimates from $2.36 to $2.77 from 4 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $2.92, with estimates from $2.62 to $3.32 from 4 analysts.
What revenue do analysts expect from Exponent next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $613.75M, with estimates from $593.18M to $672.51M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $668.69M, with estimates from $642.42M to $743.84M.
How many analysts cover EXPO?
4 analysts rate Exponent stock, and 4 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
EXPO pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts